Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Journal of Translational Medicine|April 22, 2020
High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injuryShuo Wang, Songjie Cai, Weitao Zhang, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivoAlison M Paterson, Keturah E Brown, Mary E Keir, et al.Transplantation|May 24, 2014
Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatchLeonardo V Riella, Kassem Safa, Jude Yagan, et al.European Journal of Immunology|March 26, 2013
Jagged2-signaling promotes IL-6-dependent transplant rejectionLeonardo V Riella, Jun Yang, Susanne Chock, et al.Circulation. Cardiovascular Imaging|January 16, 2024
Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney TransplantDaniel M Huck, Brittany Weber, Brittany Schreiber, et al.Journal of the American Society of Nephrology : JASN|May 25, 2001
Hepatocyte growth factor prevents the development of chronic allograft nephropathy in ratsHaruhito Azuma, Shiro Takahara, Kunio Matsumoto, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2021
Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantationMostafa T Mohammed, Songjie Cai, Benjamin L Hanson, et al.Transplantation|January 11, 2014
Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1β secretion in the peripheral bloodIbrahim Batal, Sacha A De Serres, Bechara G Mfarrej, et al.Circulation|January 24, 2008
Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathyJun Yang, Joyce Popoola, Shakila Khandwala, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2014
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trialBelinda T Lee, Steven Gabardi, Monica Grafals, et al.Pageof 11